Teal Tea Luncheon
In September, a group of ladies from Collierville, TN hosted their first Teal Tea Luncheon to support the Ovarian Cancer National Alliance. The community event included tea, lunch and speaker … Continued
News
OCRF Research Identifies Targetable Mutations in Low Grade ...
OCRF Research Identifies Targetable Mutations in Low Grade Serous Ovarian Cancer
(December 2, 2015) Research funded in part by an OCRF grant to Rachel Grisham, MD has identified new, potentially targetable mutations in patients with low grade serous ovarian cancer. Dr. … Continued
OCRF Research Offers Insight on How Ovarian Cancer Grows
OCRF Research Offers Insight on How Ovarian Cancer Grows
(December 1, 2015) Research funded in part by Ovarian Cancer Research Fund, and published in PNAS, offers new insights into how ovarian cancer grows—and the potential to stop it. Can … Continued
Better Outcomes for Ovarian Cancer Patients with History of...
Better Outcomes for Ovarian Cancer Patients with History of Oral Contraceptive Use
(November 20, 2015) A study published in BMC Cancer demonstrates that ovarian cancer patients who had a history of oral contraceptive use had better outcomes than those who had not … Continued
Ten-year Survival Not Associated with BRCA Mutation Status
Ten-year Survival Not Associated with BRCA Mutation Status
(Nov. 19, 2016) In research published this month in Gynecologic Oncology, a group of Canadian researchers have found that long-term survival is not associated with BRCA mutation status in ovarian … Continued
Public health evidence points to need for FDA regulation of...
Public health evidence points to need for FDA regulation of laboratory developed tests
November 18, 2015 Contact: Lisa Mauti lmauti@ovariancancer.org Public health evidence points to need for FDA regulation of laboratory developed tests “The consequences of inaccurate test results, such as false positives, … Continued
A Statement about LDTs
A Statement about LDTs
Washington, DC — On November 17th, the Food and Drug Administration (FDA) released a report: The Public Health Evidence for FDA Oversight of Laboratory Developed Tests: 20 Case Studies, that outlines the … Continued
Meet OCRF’s 2016 Grantees
Meet OCRF’s 2016 Grantees
OCRF has awarded $5.2 million in new grants, bringing our total investment in ovarian cancer research to nearly $70 million.
OCRF Research Explains Limits of Cancer Immunotherapy Drugs
OCRF Research Explains Limits of Cancer Immunotherapy Drugs
A new study of ovarian cancer cells from the University of Michigan Comprehensive Cancer Center, funded in part by an OCRF grant to Dr. Weiping Zou, reveals molecular changes within … Continued
Research Round Up: AACR
Earlier this month, we attended the AACR conference Advances in Ovarian Cancer Research: Exploiting Vulnerabilities, which highlighted many recent pre-clinical advancements in the treatment of ovarian cancer. Much of the … Continued
New Ovarian Cancer National Alliance research finds state l...
New Ovarian Cancer National Alliance research finds state lawmakers have power to dramatically improve access to ovarian cancer care and outcomes for the 21,000 women diagnosed each year
For Immediate ReleaseSeptember 23, 2015 New Ovarian Cancer National Alliance research finds state lawmakers have power to dramatically improve access to ovarian cancer care and outcomes for the 21,000 women … Continued
Representatives Sean Duffy (R-WI) and Rosa DeLauro (D-CT) t...
Representatives Sean Duffy (R-WI) and Rosa DeLauro (D-CT) to launch Congressional Ovarian Cancer Caucus at Rally on Tuesday
For Immediate ReleaseSeptember 28, 2015 Representatives Sean Duffy (R-WI) and Rosa DeLauro (D-CT) to launch Congressional Ovarian Cancer Caucus at Rally on Tuesday Representatives Sean Duffy (R-WI) and Rosa DeLauro … Continued